Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund II - Biotechnology Sub-Fund

+ Add to Watchlist

CARBIOA:LX

38.63 EUR

As of 00:00:00 ET on 04/24/2015.

Snapshot for Carnegie Fund II - Biotechnology Sub-Fund (CARBIOA)

Year To Date: +23.38% 3-Month: +12.92% 3-Year: +46.10% 52-Week Range: 21.19 - 39.58
1-Month: +0.42% 1-Year: +74.72% 5-Year: +34.69% Beta vs CXBT: -

Mutual Fund Chart for CARBIOA

No chart data available.
  • CARBIOA:LX 38.63
  • 1M
  • 1Y
Interactive CARBIOA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARBIOA

Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.

Inception Date: 10-10-2000 Telephone: 352-40-40-30-1
Managers: ULF ARVIDSSON
Web Site: www.carnegie.se

Fundamentals for CARBIOA

NAV (on 2015-04-24) 38.63
Assets (M) (on 2015-03-31) 36.39
Fund Leveraged N
Minimum Investment 15,000.00
Minimum Subsequent Investment -

Dividends for CARBIOA

No dividends reported

Fees & Expenses for CARBIOA

Front Load -
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.10

Top Fund Holdings for CARBIOA

Filing Date: 03/31/2015
Name Position Value % of Total
Biogen Inc 8,200 3,271,902 8.991%
Celgene Corp 27,000 2,954,323 8.118%
Gilead Sciences Inc 29,000 2,681,683 7.369%
Vertex Pharmaceuticals Inc 21,400 2,390,627 6.569%
Alexion Pharmaceuticals Inc 12,100 2,007,159 5.516%
BioMarin Pharmaceutical Inc 15,000 1,795,863 4.935%
Medivation Inc 13,800 1,692,580 4.651%
Jazz Pharmaceuticals PLC 9,000 1,473,097 4.048%
Auspex Pharmaceuticals Inc 15,500 1,448,910 3.981%
Mylan NV 26,000 1,431,659 3.934%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil